- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02481037
Primary Care Pathway for Childhood Asthma
At least half of children with asthma have poor disease control, which can result in complications requiring emergency treatment and hospitalization. As asthma is one of the most common reasons for children to visit emergency departments (ED) and be hospitalized, this disease places a heavy burden on the health care system and families. While there is strong evidence that timely treatment with preventative therapies can substantially improve asthma control, reduce sudden worsening of symptoms, and lower rates of ED visits and hospitalizations, a significant proportion of children do not receive these therapies.
The purpose of this study is to improve the prescription and use of evidenced-based preventative therapies for children with asthma with the goal to significantly improve their disease control and quality of life, while reducing unnecessary ED visits and hospitalizations. The investigators will achieve this by: i) installing a primary care clinical pathway for managing childhood asthma into clinicians' electronic medical record (EMR) to facilitate the use of best-evidence by practitioners, and ii) training chronic disease management (CDM) health professionals to provide targeted and timely asthma education to parents and children with asthma. The investigators will test this pathway and education project in a representative sample of 22 Alberta primary care practices, using a pragmatic cluster controlled trial methodology.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Alberta
-
Edmonton, Alberta, Canada
- University of Alberta
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Validated diagnosis of asthma according to CPCSSN validated definition
Exclusion Criteria:
- Children under 1 and over 17 years of age
- Children of parents who have opted out of CPCSSN data collection
- Children with validated asthma who have not attended practices in the last 2 years, or have not received bronchodilator therapy in the last 12 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention group
Embedding a primary care clinical pathway for managing childhood asthma into clinicians' electronic medical record (EMR) to facilitate practitioners utilizing best-evidence; training these practices' chronic disease management (CDM) professionals to provide asthma education to children with asthma and their parents; and clinicians receiving an EMR embedded dashboard.
|
Installing a primary care clinical pathway for managing childhood asthma into clinicians' electronic medical record (EMR) to facilitate the use of best-evidence by practitioners.
Physicians will receive web-based education through an interactive learning module regarding best management for childhood asthma and use of the primary care clinical pathway.
Chronic disease management (CDM) health professionals in practices will attend asthma education sessions delivered by an asthma educator.
This training will be then used by the CDM professional to provide targeted and timely asthma education to parents and children with asthma.
An EMR embedded dashboard will deliver real-time feedback to clinicians.
|
No Intervention: Control group
Practice will continue with routine care.
Control group will be offered the intervention at study completion, if successful.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Prescription of evidenced-based preventative therapies
Time Frame: 12 months after receiving intervention
|
The proportion of symptomatic children with asthma in the baseline and follow-up periods (separate calculations) who are appropriately treated with a preventer will be the primary outcome.
The denominator will be the number of children who meet the case definition of asthma and receive at least one prescription for an inhaled short-acting beta-agonist (e.g.
salbutamol) during the applicable time period.
The numerator will be, of these children, the number who receive a prescription for inhaled corticosteroid, montelukast, a combined inhaled long-acting beta agonist and corticosteroid, or some combination of these three drugs in the same time period.
|
12 months after receiving intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dispensed preventative therapies
Time Frame: 12 months after receiving intervention
|
The proportion of applicable children in baseline and follow-up periods who are appropriately dispensed a preventer by a pharmacy will highlight if there is a significant gap between prescriptions given and filled.
The denominator will be the same as for the primary outcome but the numerator will be the number of these children who are dispensed one or more preventer medications from newly available Pharmaceutical Information Network (PIN) data.
|
12 months after receiving intervention
|
Emergency department visits and hospitalizations for asthma
Time Frame: 12 months after receiving intervention
|
The number of asthma emergency department visits or hospitalizations (ICD10 J45 or J46) per child who meets the case definition of asthma during each time period, a measure of health care use.
|
12 months after receiving intervention
|
Electronic Medical Record (EMR) data
Time Frame: 12 months after receiving intervention
|
The research team has worked with TELUS to develop and validate a case definition and case finding algorithm for identifying children with asthma in practices.
The TELUS EMR data will provide, for all eligible children, individual categorical and continuous patient level data such as patient demographics, ICD9 codes and medication prescriptions, and for children evaluated in practices randomized to the pathway group, asthma phenotype and provision of asthma action plans.
|
12 months after receiving intervention
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Andrew Cave, FCFP, FRCGP, Department of Family Medicine, University of Alberta
Publications and helpful links
General Publications
- Sharpe H, Potestio M, Cave A, Johnson DW, Scott SD. Facilitators and barriers to the implementation of the Primary Care Asthma Paediatric Pathway: a qualitative analysis. BMJ Open. 2022 May 12;12(5):e058950. doi: 10.1136/bmjopen-2021-058950.
- Cave AJ, Sharpe H, Anselmo M, Befus AD, Currie G, Davey C, Drummond N, Graham J, Green LA, Grimshaw J, Kam K, Manca DP, Nettel-Aguirre A, Potestio ML, Rowe BH, Scott SD, Williamson T, Johnson DW. Primary Care Pathway for Childhood Asthma: Protocol for a Randomized Cluster-Controlled Trial. JMIR Res Protoc. 2016 Mar 8;5(1):e37. doi: 10.2196/resprot.5261.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 201400389
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Asthma
-
Vanderbilt University Medical CenterNot yet recruitingAsthma in Children | Asthma Attack | Asthma Acute | Acute Asthma Exacerbation | Asthma; StatusUnited States
-
University of California, San FranciscoCompletedAsthma in Children | Asthma Attack | Asthma Acute | Asthma ChronicUnited States
-
Johann Wolfgang Goethe University HospitalCompleted
-
Universita di VeronaCompleted
-
Parc de Salut MarActive, not recruitingAsthma in Children | Persistent Asthma | Asthma ExacerbationSpain
-
Forest LaboratoriesCompleted
-
Brunel UniversityKarolinska InstitutetUnknown
-
Value Outcomes Ltd.AstraZenecaCompletedAsthma, Bronchial | Bronchial Asthma | Asthma Chronic | Asthma; EosinophilicCzechia
-
Johann Wolfgang Goethe University HospitalCompletedExercise-induced AsthmaGermany
Clinical Trials on Primary care clinical pathway
-
YaNi PengCompleted
-
European Pathway AssociationKU Leuven; University of Eastern PiedmontCompletedPulmonary Disease, Chronic Obstructive
-
European Pathway AssociationKU Leuven; University of Eastern PiedmontCompleted
-
European Pathway AssociationKU LeuvenCompleted
-
Bert LeysenIntermutualistic Agency; National Institute for Health and Disability Insurance...CompletedPalliative Care | Primary Health CareBelgium
-
University of AlbertaAlberta Health servicesNot yet recruitingStaph Aureus Bacteremia
-
Wake Forest University Health SciencesCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
University of CalgaryAlberta Health services; Brain CanadaCompletedMild Traumatic Brain Injury | Pediatric Disorder | Concussion, BrainCanada
-
Aberystwyth UniversityWithdrawn
-
Universidad de AntioquiaUnknown